Akihiro Kaneko, Motoko Inomata
Journal: International journal of clinical oncology 2004;9(1):31-5
PMID: 15162823
The use of chemotherapy in treating retinoblastoma is presently increasing in importance. Because of the rarity of this disease, excellent in vitro chemosensitivity assays are necessary, not only for individualized testing but also for the development of chemotherapy regimens. It is instructive for improving such assays to discuss in vitro chemosensitivitly tests of tumor cells from clinical specimens according to a cell biological perspective. This review will first summarize and discuss the technical problems encountered with several representative in vitro chemosensitivity tests on clinical specimens, including retinoblastoma. The second part of this review will summarize the results of chemosensitivity tests on retinoblastoma specifically.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.